Head to head

Vasculight vs Venus Versa Pro (2026)

Compare purchase costs, running costs and the evidence behind each device.

Read the comparison overview

Purchase cost: The catalog lists $100k–$130k for Venus Versa Pro. No new-price range is on file for Vasculight. Check the source notes and request current quotes.
Technology: Vasculight: Nd:YAG. Venus Versa Pro: IPL.
Practice fit: Both are listed under IPL multi-app platform. Check each model’s US regulatory status and labeled indications for your intended use.

Device A

IPL multi-app platform

View full device profile →

Device B

IPL multi-app platform

View full device profile →

Price comparison

Price comparison: Lumenis Vasculight vs Venus Versa Pro
Attribute	Lumenis Vasculight	Venus Versa Pro
New price range	Not published	$100k–$130kSource not documented
Used asking range	$3k–$8kSource not documented	Not published
Payback calculator	View ROI calculator	View ROI calculator
Next step	Explore this model’s specs and owner reviews. For new-equipment inquiries, browse current models. Browse current models

New price range

Lumenis Vasculight: Not published
Venus Versa Pro: $100k–$130kSource not documented

Used asking range

Lumenis Vasculight: $3k–$8kSource not documented
Venus Versa Pro: Not published

Payback calculator

Lumenis Vasculight: View ROI calculator
Venus Versa Pro: View ROI calculator

Next step

Lumenis Vasculight

Explore this model’s specs and owner reviews. For new-equipment inquiries, browse current models.

Browse current models

Venus Versa Pro

Consumable economics

Consumable economics: Lumenis Vasculight vs Venus Versa Pro
Attribute	Lumenis Vasculight	Venus Versa Pro
Consumable cost / lock-in	—	—
Service cost	Not published	Not published

Consumable cost / lock-in

Lumenis Vasculight: —
Venus Versa Pro: —

Service cost

Lumenis Vasculight: Not published
Venus Versa Pro: Not published

FDA clearance

FDA clearance: Lumenis Vasculight vs Venus Versa Pro
Attribute	Lumenis Vasculight	Venus Versa Pro
FDA status & indication	FDA ClearedK030342 Read FDA indication wording “The Lumenis Family of Intense Pulsed-Light (IPL) and IPL/Nd:YAG laser systems (and the delivery accessories that are used with them to deliver light and/or laser energy) are indicated for use in surgical, aesthetic and cosmetic applications requiring selective photothermolysis (photocoagulation or coagulation) and hemostasis of soft tissue in the medical specialties of general and plastic surgery, and dermatology. Intense Pulsed Light Energy/ Wavelengths (515 - 1200 nm) are indicated for: * The treatment of tattoos and benign pigmented epidermal and cutaneous lesions including warts, scars and striae; LUMENIS, fNC. MODIFICATIONTO IPL AND I P W D : Y A G COMB~NAT~ONPRODUCTFAMIUES CONFlDENTIAL 6 2 V. VI. * The treatment of benign cutaneous vascular lesions, including port wine stains, hemangiomas, facial, truncal and leg telangiectasias, rosacea, melasma, angiomas and spider angiomas, poikiloderma of Civatte, leg veins and venous malformations; The removal of unwanted hair from all skin types, and to effect stable long-term, or permanent2, hair reduction in skin types I-V through selective targeting o f melanin in hair follicles. * Nd:YAG Laser Wavelength (1064 nm) is indicated for the coagulation and hemostasis of vascular lesions and soft tissue, including: * Treatment and clearance of superficial and deep telangectasias (venulectasias)and reticular veins (0.1 - 4.0 mm diameter) of the leg. The removal of unwanted hair from all skin types, and to effect stable long-term, or permanent2, hair reduction in skin types I-V through selective targeting of melanin in hair follicles.”	FDA ClearedK232192 Read FDA indication wording “The Venus Versa PRO System is a multi-application device intended to be used in aesthetic and cosmetic procedures. The SR515 and SR580 IPL applicators are indicated for the following: • Treatment of benign pigmented epidermal and cutaneous lesions including: hyperpigmentation, melasma, ephelides (freckles), lentigines, nevi, and cafe-au-lait macules. • Treatment of benign cutaneous vascular lesions including port wine stains, hemangiomas, facial, truncal and leg telangiectasias, rosacea, angiomas and spider angiomas, poikiloderma of civatte, leg veins and venous malformations. The HR650, HR690, HR650XL, and HR690XL IPL applicators are indicated for the removal of unwanted hair and to effect stable long-term or permanent hair reduction for skin types I-IV. Permanent hair reduction is defined as the longterm stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regimen. The Venus Concept ACDUAL applicator is intended to be used for the treatment of acne vulgaris. The Diamondpolar and Octipolar applicators are non-invasive devices intended for use in dermatologic and general surgery procedures for females for the non-invasive treatment of moderate to severe facial wrinkles and rhytides in Fitzpatrick skin types I-IV. The Viva MD applicator is intended for dermatological procedures requiring ablation and resurfacing of the skin.”

FDA status & indication

Lumenis Vasculight: FDA ClearedK030342
Read FDA indication wording
“The Lumenis Family of Intense Pulsed-Light (IPL) and IPL/Nd:YAG laser systems (and the delivery accessories that are used with them to deliver light and/or laser energy) are indicated for use in surgical, aesthetic and cosmetic applications requiring selective photothermolysis (photocoagulation or coagulation) and hemostasis of soft tissue in the medical specialties of general and plastic surgery, and dermatology. Intense Pulsed Light Energy/ Wavelengths (515 - 1200 nm) are indicated for: * The treatment of tattoos and benign pigmented epidermal and cutaneous lesions including warts, scars and striae; LUMENIS, fNC. MODIFICATIONTO IPL AND I P W D : Y A G COMB~NAT~ONPRODUCTFAMIUES CONFlDENTIAL 6 2 V. VI. * The treatment of benign cutaneous vascular lesions, including port wine stains, hemangiomas, facial, truncal and leg telangiectasias, rosacea, melasma, angiomas and spider angiomas, poikiloderma of Civatte, leg veins and venous malformations; The removal of unwanted hair from all skin types, and to effect stable long-term, or permanent2, hair reduction in skin types I-V through selective targeting o f melanin in hair follicles. * Nd:YAG Laser Wavelength (1064 nm) is indicated for the coagulation and hemostasis of vascular lesions and soft tissue, including: * Treatment and clearance of superficial and deep telangectasias (venulectasias)and reticular veins (0.1 - 4.0 mm diameter) of the leg. The removal of unwanted hair from all skin types, and to effect stable long-term, or permanent2, hair reduction in skin types I-V through selective targeting of melanin in hair follicles.”
Venus Versa Pro: FDA ClearedK232192
Read FDA indication wording
“The Venus Versa PRO System is a multi-application device intended to be used in aesthetic and cosmetic procedures. The SR515 and SR580 IPL applicators are indicated for the following: • Treatment of benign pigmented epidermal and cutaneous lesions including: hyperpigmentation, melasma, ephelides (freckles), lentigines, nevi, and cafe-au-lait macules. • Treatment of benign cutaneous vascular lesions including port wine stains, hemangiomas, facial, truncal and leg telangiectasias, rosacea, angiomas and spider angiomas, poikiloderma of civatte, leg veins and venous malformations. The HR650, HR690, HR650XL, and HR690XL IPL applicators are indicated for the removal of unwanted hair and to effect stable long-term or permanent hair reduction for skin types I-IV. Permanent hair reduction is defined as the longterm stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regimen. The Venus Concept ACDUAL applicator is intended to be used for the treatment of acne vulgaris. The Diamondpolar and Octipolar applicators are non-invasive devices intended for use in dermatologic and general surgery procedures for females for the non-invasive treatment of moderate to severe facial wrinkles and rhytides in Fitzpatrick skin types I-IV. The Viva MD applicator is intended for dermatological procedures requiring ablation and resurfacing of the skin.”

Which chains run each

Which chains run each: Lumenis Vasculight vs Venus Versa Pro
Attribute	Lumenis Vasculight	Venus Versa Pro
Chain adoption	0 recorded pairings	0 recorded pairings
Chains using it	—	—
Approved reviews	0	0

Chain adoption

Lumenis Vasculight: 0 recorded pairings
Venus Versa Pro: 0 recorded pairings

Chains using it

Lumenis Vasculight: —
Venus Versa Pro: —

Approved reviews

Lumenis Vasculight: 0
Venus Versa Pro: 0

Specs and platform

Specs and platform: Lumenis Vasculight vs Venus Versa Pro
Attribute	Lumenis Vasculight	Venus Versa Pro
Manufacturer	Lumenis	Venus Concept
Built by (OEM)	Lumenis Be Ltd.	Venus Concept Inc.
Category	IPL multi-app platform	IPL multi-app platform
Technology	IPL + 1064nm Nd:YAG (Nd:YAG)	Updated IPL/HR multi-app (IPL)
Launch year	2000	2023
Status	Legacy-used-market	Current
Manufacturer source record	No linked source on file.	No linked source on file.

Manufacturer

Lumenis Vasculight: Lumenis
Venus Versa Pro: Venus Concept

Built by (OEM)

Lumenis Vasculight: Lumenis Be Ltd.
Venus Versa Pro: Venus Concept Inc.

Current alternatives

Current catalog models in related categories. Confirm availability and configuration with the supplier.

InMode Envision

IPL multi-app platform

New: —

Lumenis Stellar M22

IPL multi-app platform

New: $90k–$130k

InMode Optimas

IPL multi-app platform

New: $90k–$130k

SharpLight OmniMax S4

IPL multi-app platform

New: $60k–$90k

Get a free recommendation Browse by goal

Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Price figures are references, not current offers. Check each device’s source notes. Not medical, legal or regulatory advice.